AU2002312797A1 - Peptide for the diagnosis and therapy of alzheimer's disease - Google Patents

Peptide for the diagnosis and therapy of alzheimer's disease

Info

Publication number
AU2002312797A1
AU2002312797A1 AU2002312797A AU2002312797A AU2002312797A1 AU 2002312797 A1 AU2002312797 A1 AU 2002312797A1 AU 2002312797 A AU2002312797 A AU 2002312797A AU 2002312797 A AU2002312797 A AU 2002312797A AU 2002312797 A1 AU2002312797 A1 AU 2002312797A1
Authority
AU
Australia
Prior art keywords
alzheimer
peptide
diagnosis
therapy
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002312797A
Inventor
Katja Wiesehan
Dieter Willbold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMB Institut fur Molekulare Biotechnologie eV
Original Assignee
IMB Institut fur Molekulare Biotechnologie eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMB Institut fur Molekulare Biotechnologie eV filed Critical IMB Institut fur Molekulare Biotechnologie eV
Publication of AU2002312797A1 publication Critical patent/AU2002312797A1/en
Abandoned legal-status Critical Current

Links

AU2002312797A 2001-04-06 2002-04-08 Peptide for the diagnosis and therapy of alzheimer's disease Abandoned AU2002312797A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10117281.8 2001-04-06

Publications (1)

Publication Number Publication Date
AU2002312797A1 true AU2002312797A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU2003206413A1 (en) Substituted amino carboxamides for the treatment of alzheimer's disease
EP1392287B8 (en) Use of substituted azetidinone derivatives in the treatment of Alzheimer's disease
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU2003303141A1 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
AU2002312667A1 (en) Individualization of therapy with alzheimer's disease agents
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer
AU2002357232A1 (en) Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
AU2003236714A8 (en) Diagnosis of alzheimer's disease based on the habeta42:habeta40 ratio
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
AU2002312797A1 (en) Peptide for the diagnosis and therapy of alzheimer's disease
AU2003286530A1 (en) Substituted peptides useful in the treatment of alzheimer's disease
AU2002364757A8 (en) Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
AU2003288127A1 (en) DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE
AU2002320537A1 (en) Diaminediols for the treatment of alzheimer's disease
AU2002316622A1 (en) Aminediols for the treatment of alzheimer's disease
AU2003289859A1 (en) Diagnostic and therapeutic use of arl7 for alzheimer's disease
AU2002333808A1 (en) Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders